期刊
BIOSENSORS-BASEL
卷 12, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/bios12050298
关键词
RT-LAMP; point-of-care diagnostics; microfluidics; molecular HCV test; colorimetric detection
资金
- National Institute of Health (NIH) [R61AI154643]
- National Science Foundation (NSF) [1942487]
HCV infections affect approximately 3% of the world population, requiring rapid and accurate diagnostic methods for effective disease management. A study presented an automated RT-LAMP-based molecular diagnostic set-up that can detect 500 virions/mL within 45 minutes, demonstrating high sensitivity and specificity.
Hepatitis C virus (HCV) infections occur in approximately 3% of the world population. The development of an enhanced and extensive-scale screening is required to accomplish the World Health Organization's (WHO) goal of eliminating HCV as a public health problem by 2030. However, standard testing methods are time-consuming, expensive, and challenging to deploy in remote and underdeveloped areas. Therefore, a cost-effective, rapid, and accurate point-of-care (POC) diagnostic test is needed to properly manage the disease and reduce the economic burden caused by high case numbers. Herein, we present a fully automated reverse-transcription loop-mediated isothermal amplification (RT-LAMP)-based molecular diagnostic set-up for rapid HCV detection. The set-up consists of an automated disposable microfluidic chip, a small surface heater, and a reusable magnetic actuation platform. The microfluidic chip contains multiple chambers in which the plasma sample is processed. The system utilizes SYBR green dye to detect the amplification product with the naked eye. The efficiency of the microfluidic chip was tested with human plasma samples spiked with HCV virions, and the limit of detection observed was 500 virions/mL within 45 min. The entire virus detection process was executed inside a uniquely designed, inexpensive, disposable, and self-driven microfluidic chip with high sensitivity and specificity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据